Advertisement
Advertisement

ELDN

ELDN logo

Eledon Pharmaceuticals, Inc. Common Stock

3.69
USD
Sponsored
+0.23
+6.65%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

3.75

+0.06
+1.49%

Eledon Pharmaceuticals, Inc. Common Stock Profile

About

Eledon Pharmaceuticals Inc. is a clinical stage biotechnology company. It develop treatments for an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease. Eledon Pharmaceuticals Inc., formerly known as Novus Therapeutics Inc., is based in IRVINE, Calif.

Info & Links

CEO

David-Alexandre C. Gros

Headquarters

19800 MACARTHUR BOULEVARD, SUITE 250
IRVINE, CA 92612, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.eledon.com

Auditor

Deloitte & Touche LLP

Share holders

23

Employees

33

Eledon Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

289.07M

Enterprise Value

282.92M

Enterprise Value/EBITDA(ttm)

-3.27

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

6.36

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-116.97%

Return on Invested Capital(ttm)

-76.24%

Return on Assets(ttm)

-41.91%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-86.47M

Net Income Available to Common(ttm)

-78.15M

Diluted EPS(ttm)

-0.77

Share Statistics

Beta (5Y Monthly)

0.98

52-Week Change

35.91%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

77.19M

Dividend Yield

0.00%

Float4

69.78M

% Held by Insiders

9.60%

% Held by Institutions

56.77%

Balance Sheet

Total Cash(mrq)

111.09M

Total Cash Per Share(mrq)

1.44

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.44%

Quick Ratio(mrq)

8.44%

Book Value Per Share(mrq)

1.32

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.20

Free Cash Flow(ytd)

-22.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement